NTRK1 and glioblastoma: The Cancer Genome Atlas (TCGA) has provided valuable insights into the key genetic changes present in GBM, highlighting three major pathways: receptor tyrosine kinase (RTK)/rat sarcoma (RAS)/PI3K (found in 88% of cases), p53 (78%), and retinoblastoma (RB) (87%).